Newly-developed blood test could predict severity of COVID-19 infections

Scientists have developed a blood test that could help doctors predict whether a COVID-19 patient may need intensive care shortly after they develop symptoms, reports The Guardian. It may even predict how likely they are to survive the infection.
The team of scientists initially identified 27 proteins in the blood of COVID-19 patients that were present at different levels depending on symptom severity, and since then they've followed 160 patients who had their blood tested to determine if their protein signature could predict the progression of their illness. If the hypothesis is validated in hospital settings in the coming weeks, the test could be crucial in helping doctors choose whether to provide life-saving treatment in the earlier stages of infection. The coronavirus has proven particularly challenging because some patients will sometimes report feeling relatively well and then rapidly deteriorate, so the blood test could potentially help catch those cases, The Guardian notes.
"It turns out that such patients have an early inflammatory response to the infection, which we can measure in the blood and use to say, 'OK, 40 days down the line, this is your likely outcome'," said Ralser, a professor of biochemistry at the Francis Crick Institute in London and Charité University Medicine in Berlin. "Every day counts with severe COVID, and those people who need intensive care need to get it as soon as possible because this greatly increases their chances of survival."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The test, like many COVID-19-related developments, wouldn't be a singular tool, but instead could provide important data for health care workers who are faced with difficult decisions. Read more at The Guardian.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Rep. Sylvester Turner dies, weeks after joining House
Speed Read The former Houston mayor and longtime state legislator left behind a final message for Trump: 'Don't mess with Medicaid'
By Peter Weber, The Week US Published
-
Trump pauses Ukraine intelligence sharing
Speed Read The decision is intended to pressure Ukrainian President Volodymyr Zelenskyy into peace negotiations with Vladimir Putin
By Peter Weber, The Week US Published
-
Supreme Court rules against Trump on aid freeze
Speed Read The court rejected the president's request to freeze nearly $2 billion in payments for foreign humanitarian work
By Rafi Schwartz, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published